Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tilla S Worgall

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Current Opinion in Clinical Nutrition and Metabolic Care|February 13, 2009
Lipid metabolism in cystic fibrosisTilla S Worgall
Current Opinion in Clinical Nutrition and Metabolic Care|February 8, 2007
Sphingolipids: major regulators of lipid metabolismTilla S Worgall
Advances in Experimental Medicine and Biology|May 3, 2022
Sphingolipids and AsthmaTilla S Worgall
Sub-Cellular Biochemistry|August 30, 2008
Regulation of lipid metabolism by sphingolipidsTilla S Worgall
Current Opinion in Clinical Nutrition and Metabolic Care|December 29, 2016
Sphingolipids, ORMDL3 and asthma: what is the evidence?Tilla S Worgall
Respirology (Carlton, Vic.)|July 27, 2010
Lipoprotein patterns in adult cystic fibrosis: a cause for concern or marker for survival?Tilla S Worgall
Advances in Experimental Medicine and Biology|September 13, 2011
Sphingolipid synthetic pathways are major regulators of lipid homeostasisTilla S Worgall
Atherosclerosis|October 19, 2012
Sphingolipids and atherosclerosisThorsten Hornemann, Tilla S Worgall
Current Opinion in Chemical Biology|August 24, 2010
Detecting hydrophobic molecules with nucleic acid-based receptorsMilan N Stojanovic, Tilla S Worgall
Pediatric Research|October 30, 2013
17q21 locus and ORMDL3: an increased risk for childhood asthmaJennie G Ono, Tilla S Worgall, Stefan Worgall
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Current Opinion in Clinical Nutrition and Metabolic Care|February 13, 2009
Lipid metabolism in cystic fibrosisTilla S Worgall
Current Opinion in Clinical Nutrition and Metabolic Care|February 8, 2007
Sphingolipids: major regulators of lipid metabolismTilla S Worgall
Advances in Experimental Medicine and Biology|May 3, 2022
Sphingolipids and AsthmaTilla S Worgall
Sub-Cellular Biochemistry|August 30, 2008
Regulation of lipid metabolism by sphingolipidsTilla S Worgall
Current Opinion in Clinical Nutrition and Metabolic Care|December 29, 2016
Sphingolipids, ORMDL3 and asthma: what is the evidence?Tilla S Worgall
Respirology (Carlton, Vic.)|July 27, 2010
Lipoprotein patterns in adult cystic fibrosis: a cause for concern or marker for survival?Tilla S Worgall
Advances in Experimental Medicine and Biology|September 13, 2011
Sphingolipid synthetic pathways are major regulators of lipid homeostasisTilla S Worgall
Atherosclerosis|October 19, 2012
Sphingolipids and atherosclerosisThorsten Hornemann, Tilla S Worgall
Current Opinion in Chemical Biology|August 24, 2010
Detecting hydrophobic molecules with nucleic acid-based receptorsMilan N Stojanovic, Tilla S Worgall
Pediatric Research|October 30, 2013
17q21 locus and ORMDL3: an increased risk for childhood asthmaJennie G Ono, Tilla S Worgall, Stefan Worgall
Pageof 6